Peter Fernandes
Presidente en The Pulmonary Vascular Research Institute .
Fortuna: 2 079 $ al 31/05/2024
Cargos activos de Peter Fernandes
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
The Pulmonary Vascular Research Institute
 The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Presidente | - | - |
Historial de carrera de Peter Fernandes
Antiguos cargos conocidos de Peter Fernandes.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BELLEROPHON THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 05/05/2023 | 15/11/2023 |
| Director Ejecutivo | 11/11/2021 | 15/11/2023 | |
| Director Financiero/CFO | 05/05/2023 | 15/11/2023 | |
| Consejero General | 20/05/2015 | 15/11/2023 | |
| IKARIA, INC. | Consejero General | 01/10/2012 | 01/05/2015 |
| OPTINOSE, INC. | Consejero General | 01/10/2010 | 01/09/2012 |
| Novartis Pharmaceuticals AG | Corporate Officer/Principal | 01/11/2007 | 01/10/2010 |
ALTANA Pharma US, Inc.
 ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Consejero General | 01/02/2005 | 01/10/2007 |
Formación de Peter Fernandes.
| The Grant Government Medical College | Graduate Degree |
| Principal K. M. Kundnani College of Pharmacy | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| India | 3 |
| Reino Unido | 2 |
Operativa
| General Counsel | 4 |
| Comptroller/Controller/Auditor | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| BELLEROPHON THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
ALTANA Pharma US, Inc.
ALTANA Pharma US, Inc. Pharmaceuticals: MajorHealth Technology ALTANA Pharma US, Inc. develops respiratory and gastrointestinal products. The company is headquartered in Florham Park, NJ. | Health Technology |
The Pulmonary Vascular Research Institute
The Pulmonary Vascular Research Institute Miscellaneous Commercial ServicesCommercial Services The Pulmonary Vascular Research Institute operates as a medical research charity. The non-profit company is based in Canterbury, UK. | Commercial Services |
| Novartis Pharmaceuticals AG |
- Bolsa de valores
- Insiders
- Peter Fernandes
- Experiencia
